Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$40.4 - $59.1 $6.86 Million - $10 Million
-169,684 Reduced 13.78%
1,061,398 $43.2 Million
Q1 2023

May 11, 2023

BUY
$38.16 - $48.86 $183,816 - $235,358
4,817 Added 0.39%
1,231,082 $59.6 Million
Q4 2022

Feb 10, 2023

SELL
$33.53 - $54.79 $13.2 Million - $21.5 Million
-392,629 Reduced 24.25%
1,226,265 $46.8 Million
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $750,830 - $966,122
-17,941 Reduced 1.1%
1,618,894 $81.3 Million
Q2 2022

Aug 05, 2022

SELL
$25.6 - $45.23 $254,694 - $449,993
-9,949 Reduced 0.6%
1,636,835 $65.6 Million
Q1 2022

May 13, 2022

BUY
$33.33 - $44.6 $3.68 Million - $4.93 Million
110,561 Added 7.2%
1,646,784 $61.4 Million
Q4 2021

Feb 14, 2022

BUY
$35.36 - $41.86 $8.77 Million - $10.4 Million
247,968 Added 19.25%
1,536,223 $61.2 Million
Q3 2021

Nov 12, 2021

BUY
$37.01 - $44.74 $14.2 Million - $17.2 Million
383,338 Added 42.36%
1,288,255 $47.9 Million
Q2 2021

Aug 13, 2021

BUY
$37.95 - $49.37 $74,040 - $96,320
1,951 Added 0.22%
904,917 $38.3 Million
Q1 2021

May 17, 2021

BUY
$46.8 - $68.92 $1.76 Million - $2.58 Million
37,506 Added 4.33%
902,966 $42.8 Million
Q4 2020

Feb 12, 2021

BUY
$47.96 - $67.64 $3.24 Million - $4.58 Million
67,643 Added 8.48%
865,460 $52.8 Million
Q3 2020

Nov 12, 2020

BUY
$45.41 - $57.07 $5.96 Million - $7.49 Million
131,287 Added 19.7%
797,817 $37.3 Million
Q2 2020

Aug 14, 2020

BUY
$42.56 - $54.98 $9.68 Million - $12.5 Million
227,379 Added 51.78%
666,530 $33.8 Million
Q1 2020

May 15, 2020

BUY
$32.37 - $59.36 $86,298 - $158,253
2,666 Added 0.61%
439,151 $19.6 Million
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $1.59 Million - $2.47 Million
49,258 Added 12.72%
436,485 $21 Million
Q3 2019

Nov 13, 2019

BUY
$33.82 - $48.17 $13.1 Million - $18.7 Million
387,227 New
387,227 $13.1 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.